2014

Unilife Launches Free Investor Relations App for the iPhone® Investors can download the new mobile app at Apple's App Store™

YORK, Pa., March 12, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced the release of its investor relations app, now available for free at the App Store™ on the iPhone®.

The Unilife investor relations app for iPhone allows users to navigate the Company's investor relations materials, as well as receive a stock quote and other important stock information. Developed and powered by KCSA Strategic Communications, the Unilife app features the latest press releases and SEC filings as well as background information, videos and presentations from the Company.

"The Unilife investor relations app for iPhone will help our existing and potential shareholders more easily track our company's updates and stock trading activity. This is increasingly important for those tracking our Company as we look to release a steady flow of positive news this year," commented Alan Shortall, Chief Executive Officer of Unilife.

"All investors are increasingly using mobile technologies to stay up-to-date on the latest company news and market events.  By launching the Unilife investor relations app, we are offering our investors a direct path to the most pertinent information surrounding our IR activities, including our latest news releases, SEC filings, audio casts and covering analysts' contact info."

To be added to the Unilife investor email list, please email investors@unilife.com or go to the Unilife website at http://ir.unilife.com/alerts.cfm.

Become a Unilife fan and follow the Company on Facebook at http://www.facebook.com/unilifecorp

About Unilife Corporation

Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of advanced drug delivery systems. Unilife collaborates with pharmaceutical and biotechnology companies seeking innovative, differentiated devices that can enable or enhance the delivery of injectable drugs and vaccines supplied in either a liquid stable or lyophilized form. The Unifill syringe, the world's first and only prefilled syringe with fully integrated safety features, sits at the leading edge of this diversified portfolio. In addition to prefilled and hypodermic safety syringes with automatic, user-controlled needle retraction, Unilife has other proprietary technology platforms including drug reconstitution delivery systems, auto-injectors, auto-infusion pump systems and specialized devices for targeted organ delivery. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information on Unilife, please visit www.unilife.com   

Forward-Looking Statements

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

General: UNIS-G

Investor Contacts (US):     

Analyst Enquiries     

Investor Contacts (Australia)

Todd Fromer / Garth Russell     

Lynn Piper     

Jeff Carter

KCSA Strategic Communications     

Westwicke Partners     

Unilife Corporation

P: + 1 212-682-6300     

P: + 1 415-202-5678     

P: + 61 2 8346 6500

 

SOURCE Unilife Corporation



RELATED LINKS
http://www.unilife.com

More by this Source

View all news by Unilife Corporation

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.